Switch View
© PR Newswire
25.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf to Report Third Quarter 2025 Financial and Operational Results
News Preview
STAMFORD, Conn., Sept. 25, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
News Preview
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET th...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf to Report Third Quarter 2025 Financial and Operational Results
News Preview
STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
25.09.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the groundbreaking of its new state-of-the-art research, development, and manufacturing facility in Huntsville, Alabama. The new site repre...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
25.09.2025
ISIN: US45780L1044
Inogen Inc
INGN
LISTED
NASDAQ
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer
News Preview
Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga Rameswamy as Chief Technology Officer, effective September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, where he served as the Vice President and Global Head of Digi...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva to Host Virtual Investor Day on October 16, 2025
News Preview
PLEASANTON, Calif., Sept. 25, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, October 16, 2025. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT.
Veeva will broadcast the presentations live on the company's investor relations website, ir.veeva.com, where a link...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LIFEMD, INC. (LFMD), CONTACT THE LAW OF...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US00216W2089
ATI Physical Therapy Inc
ATIP
LISTED
NYSE
ATI Physical Therapy Recognized for Commitment to Safety in Use of Dry Needling
News Preview
'NeedleCert PrivilegePath' drives exceptional learner adoption and clinical consistency
DOWNERS GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- ATI Physical Therapy, a nationally recognized provider of outpatient physical therapy and rehabilitation services, has been named the winner of the Best Training Adoption Award in Absorb Software's 2025 Absor...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio
News Preview
A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Monday, 29 September at 9:00am CT in the United States Courthouse in Pensacola, Florida. The hearing will address oral arguments from the plaintiffs and defendants concerning the issue of pre-emption. The pre-emption defence is common in drug litigation. I...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US22663K1079
Crinetics Pharmaceuticals Inc
CRNX
LISTED
NASDAQ
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly
News Preview
Palsonify is approved by the U.S. FDA to treat adults with acromegaly...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
News Preview
Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
25.09.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
News Preview
– KOMET-001 in R/R NPM1-m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses –...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA58490H1073
Medicenna Therapeutics Corp
MDNA
LISTED
TSX
Medicenna Announces Results of Annual Meeting of Shareholders
News Preview
Medicenna Announces Results of Annual Meeting of Shareholders...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Provides Update on Second Phase 3 ReNu® Study
News Preview
Company maintains confidence in ReNu as innovative pain management therapy...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Encompass Health Rehabilitation Hospital of Danbury now open in Connecticut
News Preview
The Company's first location in the state is now accepting patients.
BIRMINGHAM, Ala. and DANBURY, Conn., Sept. 25, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of its first location in the state of Connecticut: Encompass Health Rehabilitation Ho...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva Releases Q3 2025 Aide Memoire
News Preview
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its website....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
News Preview
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday, November 5, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day,...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
News Preview
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Opportunities Conference, which will be held October 9, 2025 at the Metropolitan Club in New York City. Management will hold one-on-one meetings with inv...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US68404L2016
Option Care Health Inc
OPCH
LISTED
NASDAQ
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
News Preview
BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 before the m...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US17166A1016
Cibus Inc
CBUS
LISTED
NASDAQ
Cibus Announces the Election of Kimberly A. Box to Board of Directors
News Preview
Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its a...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
Harrow Launches Harrow Access for All (HAFA)
News Preview
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
News Preview
- Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA98420N1050
Xenon Pharmaceuticals Inc.
XENE
LISTED
NASDAQ
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
News Preview
VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced that the company will host an investor w...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
News Preview
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
In the Phase 3 EMBER-3 trial, Inluriyo monotherapy reduced the risk of progression or death by 38% versus endocrine therapy among patients with ESR1-mutated MBC
INDIANAPOLIS, Sept. 25, 2025 /PRNews...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US9495031067
Wellgistics Health, Inc.
WGRX
LISTED
NASDAQ
Wellgistics Health Announces Pricing of $5 Million Public Offering
News Preview
TAMPA, FL / ACCESS Newswire / September 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862 shares of common stock, together with warrants to purchase up to 7,142,862 sha...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2025
News Preview
Lyon, France – 25 septembre 2025 – 18h CEST – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui ses résultats semestriels au 30 juin 2025.
Mathieu Charvériat, Président directeur général de Theranexus, d&eacut...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
News Preview
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Lyon, France – 25 September 2025 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its first half results as of 30 June 2025.
Mathieu Charvériat, Chairman and CEO of Theranexus, comments: &ldq...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US16359R1032
Chemed Corp
CHE
LISTED
NYSE
VITAS® Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA
News Preview
MIRAMAR, Fla., Sept. 25, 2025 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has been named a 2025 Top Workplace in Healthcare by Top Workplaces USA, a national program that honors organizations based solely on employee feedback. VITAS is one of only 57 healthcare organizations nationwide with more than 1,000...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of NUTX during the cla...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Sunshine Health Awards Over $100,000 in Grants to Strengthen Florida Communities
News Preview
FORT LAUDERDALE. Fla., Sept. 25, 2025 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE: CNC), has awarded $106,000 in "Get to Know Us" grants to 50 nonprofit organizations across Florida that deliver vital programs addressing health-related social needs....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that Dr. Paul Larson will be joining the company as Chief Medical Officer starting in January 2...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US83558L2043
Sonoma Pharmaceuticals, Inc.
SNOA
LISTED
NASDAQ
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
News Preview
BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and an...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
News Preview
Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250925537941/en/From Left to...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
News Preview
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
News Preview
SECAUCUS, N.J., Sept. 25, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial results on Tuesday, October 21, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /CNW/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue accelerati...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue acc...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue acc...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025
News Preview
GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company’s software solution for radiation therapy workflow management, designed to reduce the time it takes for patients to go from diagnosis to treatment. The iRT solution is AI-supported by GE HealthCare and third-party applications,...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
News Preview
SAN DIEGO, Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry O'Neil, President and Medical Director of Urgent Care Pros....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Investors in Altimmune, Inc. Should Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Lawsuit - LNTH
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who purchased shares of LNTH during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Shareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders who purchased shares of CYTK during the class period listed are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Lost Money on Savara Inc.(SVRA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased shares of SVRA during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholders that lost money on Semler Scientific, Inc.(SMLR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Shareholders that lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Participate in Upcoming Scientific Conferences
News Preview
Several presentations to highlight key aspects of lead product candidate, INO-3107, as a potential treatment for Recurrent Respiratory Papillomatosis (RRP)Additional presentations focus on promise of next-generation DNA medicine technology, including the first preclinical data describing potential for DNA-encoded protein technology (DPROT) to add...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
News Preview
Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today ann...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US75120L1008
Rallybio Corp
RLYB
LISTED
NASDAQ
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
News Preview
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced the completion of dosing of the first cohort in the Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) study evaluating RLYB116, the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has committed more than $6.5 million in grant funding toward strengthening science, technology, engineering and math (STEM) education pathways in the San Francisco Bay Area and beyond. The funding, distributed through the Gilead Foundation, will build on the company’s ongoing work to cul...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will introduce pediatricians to GeneDx’s Infinity, the company’s proprietary dataset, at the American Academy of Pediatrics (AAP) National Conference & Exhibition taking place this weekend September 26 to 30 in Denver, CO. Infinit...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
News Preview
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific Meeting in Minneapolis, Minnesota, September 26-29, 2025.
In July 2025, the U.S. Food and Drug Administration (FDA) approved a new indication for KERENDIA...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,9...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
News Preview
WASHINGTON, Sept. 25, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" in PLOS One, a leading open-access journal....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
News Preview
CAMBRIDGE, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran (nex-z) for the treatment o...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Announces Key Advancements Across Kidney Portfolio
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). These updates represent significant progress toward reaching the Company’s goal of bringing forw...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability
News Preview
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining stable protein expression after passaging for 60 generations, w...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
